MetaADEDB 2.0 @ LMMD
penciclovir
(JNTOCHDNEULJHD-UHFFFAOYSA-N)
Structure
SMILES
OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO
Type(s)
Approved
ATC code(s)
D06BB06; J05AB13
Molecular Formula:
C10H15N5O3
Molecular Weight:
253.258
Log P:
-0.7261
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
4
TPSA:
130.05
CAS Number(s):
39809-25-1
Synonym(s)
1.
penciclovir
2.
9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine
3.
BRL 39123
4.
BRL-39123
5.
Denavir
6.
Penciclovir Visfarm
7.
Vectavir
8.
penciclovir, monosodium salt
9.
penciclovir, monosodium salt, monohydrate
External Link(s)
MeSHC053539
PubChem Compound135398748
4725
BindingDB50210804
ChEBI7956
CHEMBLCHEMBL1540
DrugBankDB00299
DrugCentral2079
KEGGcpd:C07417
dr:D05407
Therapeutic Target DatabaseD07BYK
D0M1EQ
ZINC1899
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 10US FAERS
2Expired product administeredFAERS: 5US FAERS
3Lip swellingFAERS: 3US FAERS
4No adverse eventFAERS: 3US FAERS
5Product physical consistency issueFAERS: 3US FAERS
6Application site burnFAERS: 2US FAERS
7Application site erythemaFAERS: 2US FAERS
8Application site reactionFAERS: 2SIDER
US FAERS
9CheilitisFAERS: 2US FAERS
10Incorrect drug administration durationFAERS: 2US FAERS
11StomatitisFAERS: 2US FAERS
12Application site painFAERS: 1US FAERS
13Application site vesiclesFAERS: 1US FAERS
14Burning sensationFAERS: 1US FAERS
15CellulitisFAERS: 1US FAERS
16Drug administered at inappropriate siteFAERS: 1US FAERS
17FatigueFAERS: 1SIDER
US FAERS
18HeadacheFAERS: 1SIDER
US FAERS
19Hypoaesthesia facialFAERS: 1US FAERS
20Inappropriate schedule of drug administrationFAERS: 1US FAERS
21Incorrect route of drug administrationFAERS: 1US FAERS
22Lichen PlanusFAERS: 1US FAERS
23Oral candidiasisFAERS: 1US FAERS
24PruritusFAERS: 1SIDER
US FAERS
25ScabFAERS: 1US FAERS
26Tongue blisteringFAERS: 1US FAERS
27Wrong drug administeredFAERS: 1US FAERS
28Wrong technique in drug usage processFAERS: 1US FAERS
29Wrong technique in product usage processFAERS: 1US FAERS
30Abdominal PainSIDER
31AngioedemaSIDER
32AstheniaSIDER
33Blood and lymphatic system disordersSIDER
34DeliriumSIDER
35DermatitisSIDER
36DisorientationSIDER
37DizzinessSIDER
38DysgeusiaSIDER
39Erythema MultiformeSIDER
40ErythemaSIDER
41Feeling abnormalSIDER
42FlatulenceSIDER
43Gastrointestinal PainSIDER
44Hepatitis B10353255
10418752
12760870		CTD
45Herpes LabialisSIDER
46HypersensitivitySIDER
47Leukocytoclastic vasculitisSIDER
48LeukopeniaSIDER
49NauseaSIDER
50NeutropeniaSIDER
51PainSIDER
52PalpitationsSIDER
53Rash erythematousSIDER
54SomnolenceSIDER
55Stevens-Johnson SyndromeSIDER
56ThrombocytopeniaSIDER
57Toxic Epidermal NecrolysisSIDER
58UrticariaSIDER
59VomitingSIDER
60nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.